Evidence map›Paper›PMID 40011397›Full record

ArticleJournal of clinical monitoring and computing2025

DiCART

Alexandre Descamps, Matthias Jacquet-Lagrèze, Thomas Aussal, Jean-Luc Fellahi, Martin Ruste

Registry-linked trialAbstract readValidation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical monitoring and computing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05847998 (Second Generation DICART Prototype Validation for Patients With Acute Circulatory Failure), which is not on this map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05847998 nacompletednot on this map

Second Generation DICART Prototype Validation for Patients With Acute Circulatory Failure

TypeinterventionalSponsorHospices Civils de LyonRan2023 to 2023Enrolled25ConditionsAcute Circulatory Failure, ShockArmsStandardized measurement of capillary refill time by second generation DICART prototype, Clinical measurement of capillary refill time
3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alexandre DescampsService d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France.
Matthias Jacquet-LagrèzeService d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France.
Thomas AussalService d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France.
Jean-Luc FellahiService d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France.
Martin RusteService d'anesthésie-réanimation, Hôpital cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France. martin.ruste@chu-lyon.fr.ORCID 0000-0001-6831-2519

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Capillary Refill Time (CRT) is a valuable metric to assess cutaneous perfusion. Its prognostic value in patients with acute circulatory failure has been reported as improved when the measurement is standardized. The DiCART™ device is a fully automated CRT measurement tool requiring validation. We conducted a comparative interventional single-center study including 25 patients with acute circulatory failure, to evaluate the agreement between CRT measured by an automated measurement device (CRT

Indexed as

CapillariesShockAcute DiseaseAgedAged, 80 and overEquipment DesignFemaleFingersHumansMaleMicrocirculationMiddle AgedMonitoring, PhysiologicPrognosisReproducibility of ResultsSkinAcute circulatory failureCapillary refill timeDiCART™Validation, agreement

Identifiers

PMID40011397
PMCPMC12474624

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.